Gilead Sciences Inc said on Monday it has priced its COVID-19 treatment candidate remdesivir at US$390 per vial in the United States and other ...
Gilead Sciences Inc said on Monday it has priced its COVID-19 treatment candidate remdesivir at US$390 per vial in the United States and other developed countries.
FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease , in CaliforniaREUTERS: Gilead Sciences Inc said on Monday it has priced its COVID-19 treatment candidate remdesivir at US$390 per vial in the United States and other developed countries. Based on current treatment patterns, the vast majority of patients are expected to receive a five-day treatment course using six vials of remdesivir, which equates to US$2,340 per patient, the company said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Commentary: The US is still key to the post-COVID-19 economic leadershipAs the world’s largest economy and dominant global player, the US can drive – or undermine – global policy coordination, says Mohamed A El-Erian.
Read more »
Beijing residents worry over takeaway orders after deliveryman diagnosed with Covid-19BEIJING - Since the coronavirus outbreak in China, delivery rider Wu Jun always took extra precautions on the job.. Read more at straitstimes.com.
Read more »
Global Covid-19 deaths reach 500,000 as pandemic gains momentumNEW YORK (BLOOMBERG) - Deaths from the coronavirus worldwide topped 500,000 and infections surged past 10 million, two chilling reminders that the deadliest pandemic of the modern era is stronger than ever.. Read more at straitstimes.com.
Read more »